| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | CS17H9370C |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C14H24N2O |
| Molecular Weight | 236.36 |
| AlogP | 2.13 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 58.28 |
| Molecular species | None |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 17.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Serine/threonine-protein kinase PLK1 inhibitor | Other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 1 | D009369 | ClinicalTrials |
Related Entries
MCS
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1037254-47-9 |
| ChEMBL | CHEMBL3545077 |
| FDA SRS | CS17H9370C |
| PubChem | 67313626 |
CONTENTS